Which Segment Of The Clinical Trials Market To Showcase The Highest Growth Rate By 2030?

 Clinical Trials Industry Overview

The global clinical trials market size was valued at USD 47.0 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 5.8% from 2022 to 2030. However, the market growth was hindered in 2020 due to the COVID-19 pandemic. In 2020, Parexel and Synairgen plc formed a strategic collaboration for conducting a Phase III study of an Interferon-beta (IFN-beta) treatment for COVID-19 patients. Such strategic initiatives by CROs are expected to minimize the hindrance and boost the market growth. Hence, the market is expected to grow owing to factors such as globalization of clinical trials, rapid technological evolution, and a rise in demand for CROs for conducting research activities.

The current pandemic has led to changing the ways of conducting ongoing or upcoming clinical trials. Regulatory agencies, such as the U.S. FDA, the European Medicines Agency (EMA), the National Institutes of Health (NIH), and China’s National Medical Products Administration, have issued various guidelines for conducting trials during the pandemic, which completely supports the implementation of virtual services. The current scenario across the globe and the need for several new treatment options have also led to the conducting of fast-track clinical trials.

Gather more insights about the market drivers, restrains and growth of the Global Clinical Trials market

Favorable government support is boosting the market growth, for instance, the WHO launched “Solidarity”, an international clinical trial launched to determine effective treatment against COVID-19. It includes comparing four treatment options against the standard of care to evaluate their effectiveness against the coronavirus. The WHO also announced an international alliance in May, for simultaneously developing multiple candidate vaccines to prevent the spread of the coronavirus disease, calling this effort the Solidarity trial for vaccines.

 

Browse through Grand View Research's Healthcare IT Industry Research Reports.

  • COVID-19 Vaccines Market - The introduction of a safe and effective product by 2021 seems highly possible as multiple candidates have entered Phase II trials. Unprecedented research efforts, in terms of both speed and scale, by hundreds of research groups are anticipated to bring a fundamental and necessary change in the traditional pathway for vaccine development and commercialization.

 

  • Gaucher Disease Drugs Market - The global gaucher disease (GD) drugs market size was valued at USD 1.55 billion in 2017. It is anticipated to expand at a CAGR of 1.1% during the forecast period. Gaucher disease is an autosomal recessive metabolic disorder, with an average prevalence of 1 in 100,000 individuals. It is the most common lysosomal storage disorder.



Clinical Trials Market Segmentation

Grand View Research has segmented the global clinical trials market based on phase, study design, indication by study design, sponsor, indication, and region:

 

  • Phase Outlook (Revenue, USD Million, 2017 - 2030)
    • Phase I
    • Phase II
    • Phase III
    • Phase IV

 

  • Study Design Outlook (Revenue, USD Million, 2017 - 2030)
    • Interventional
    • Observational
    • Expanded Access

 

  • Indication Outlook (Revenue, USD Million, 2017 - 2030)
    • Autoimmune/Inflammation
      • Rheumatoid arthritis
      • Multiple Sclerosis
      • Osteoarthritis
      • Irritable Bowel Syndrome (IBS)
      • Others
    • Pain Management
      • Chronic Pain
      • Acute Pain
    • Oncology
      • Blood Cancer
      • Solid Tumors
      • Other
    • CNS Condition
      • Epilepsy
      • Parkinson's Disease (PD)
      • Huntington's Disease
      • Stroke
      • Traumatic Brain Injury (TBI)
      • Amyotrophic Lateral Sclerosis (ALS)
      • Muscle Regeneration
      • Others
    • Diabetes
    • Obesity
    • Cardiovascular
    • Others

 

  • Indication by Study Design Outlook (Revenue, USD Million, 2017 - 2030)
    • Autoimmune/Inflammation
      • Interventional
      • Observational
      • Expanded Access
    • Pain Management
      • Interventional
      • Observational
      • Expanded Access
    • Oncology
      • Interventional
      • Observational
      • Expanded Access
    • CNS Condition
      • Interventional
      • Observational
      • Expanded Access
    • Diabetes
      • Interventional
      • Observational
      • Expanded Access
    • Obesity
      • Interventional
      • Observational
      • Expanded Access
    • Cardiovascular
      • Interventional
      • Observational
      • Expanded Access
    • Others
      • Interventional
      • Observational
      • Expanded Access

 

  • Sponsor Outlook (Revenue, USD Million, 2017 - 2030)
    • Pharmaceutical & Biopharmaceutical Companies
    • Medical Device Companies
    • Others

 

  • Regional Outlook (Revenue, USD Million, 2017 - 2030)
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa (MEA)

 

Market Share Insights

  • January 2020: Wuxi AppTec announced offering a fully integrated adeno-associated virus vector suspension platform to accelerate the development, manufacture, and launch of cell & gene therapy, thus expanding its service capabilities.
  • June 2018: is of Acurian and Synexus, a part of PPD, wherein they launched SynexusPlus, a site solution for patient enrollment in clinical studies. This initiative is anticipated to improve clinical trial productivity.

 

Key Companies profiled:

Some prominent players in the global clinical trials market include

  • IQVIA
  • PAREXEL International Corporation
  • Pharmaceutical Product Development, LLC
  • Charles River Laboratory
  • ICON Plc
  • PRA Health Sciences
  • Syneos Health
  • Eli Lilly and Company
  • Novo Nordisk A/S
  • Pfizer
  • Clinipace


Order a free sample PDF of the Clinical Trials Market Intelligence Study, published by Grand View Research. 

Comments

Post a Comment

Popular posts from this blog

What Are The Factors Driving The Reusable Water Bottle Market By 2030?

  Reusable Water Bottle Industry Overview The global reusable water bottle market size was valued at USD 8.64 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 4.3% from 2022 to 2030. The growing awareness regarding the environmental hazard has motivated people to take on the responsibility of reducing their contribution to the plastic problem. As a result, a large number of consumers across the globe have been replacing single-use plastic bottles with reusable water bottles. Moreover, the COVID-19 home isolation guidelines have, nevertheless, spurred the demand for various kitchen products, including reusable bottles. According to a blog post by Klarna, millennials and Generation X used a large portion of their income on home and garden products during the lockdown. These items included drinkware, kitchenware, as well as other household products. Consumers across the globe are increasingly opting for reusable water bottles at workplaces, colleg...
Read more

Farm Tire Market: Bias Tires Are Expected To Witness The Fastest Growth In Terms Of Revenue From 2021 To 2028

  Farm Tire Industry Overview The global  farm tire market  size is expected to reach USD 11.16 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 5.1% from 2021 to 2028. The growing demand for tractors and harvesters in farming activities in developed as well as developing economies is anticipated to benefit the growth of the market over the forecast period.   The demand for farm tires in agricultural vehicles is expected to witness significant growth owing to the increasing penetration of vehicles in the agricultural sector. In addition, rising awareness among farmers related to the up-gradation in automotive technology and the use of automated equipment is expected to boost the market growth. Farm Tire Market Segmentation Grand View Research has segmented the global farm tire market on the basis of product, application, distribution, and region: Based on the Product Insights, the market is segmented ...
Read more

North America Tabletop Kitchen Products Market: Flatware Segment Is Projected To Register A Significant CAGR Of 5.1% From 2021 To 2028

  North America Tabletop Kitchen Products Industry Overview The  North America tabletop kitchen products market  size is expected to reach USD 17.03 billion by 2028, registering a CAGR of 4.8% from 2021 to 2028, according to a new report by Grand View Research, Inc. The rising number of eateries and restaurants has driven the need for various  tabletop kitchen products  for the preparation, service, and delivery of various kinds of foods. The rapid growth of the real estate industry and a rise in commercial construction activities in the region are also likely to boost market growth in the coming years.   Rising disposable income, changing lifestyles, and an increasing number of houses are expected to drive the product demand over the forecast period. However, the growing popularity of disposable dinnerware, flatware, and drinkware products is a major factor behind the declining usage of tabletop products in the residential and commercial sectors. Rapid ...
Read more